Low dose aspirin to lower inflammation and prevent endometrial cancer
Treatments studied
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests whether taking a low dose of aspirin daily can reduce inflammation and help prevent endometrial cancer in women after menopause who have uterine changes and pain. If you are postmenopausal, have ongoing pelvic pain, and your doctor has recommended a biopsy of the uterine lining, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are past menopause (no period for over a year, or confirmed by blood tests)
- You have pelvic or abdominal pain that suggests inflammation
- You have had a transvaginal ultrasound and are scheduled for a biopsy of the uterine lining
- You have NOT had your uterus removed (hysterectomy) and do not have a cancer diagnosis
- You can safely stop taking blood thinners (other than aspirin) and have never had a bad reaction to aspirin or NSAIDs like ibuprofen
- You are willing to provide blood, tissue, and urine samples for research
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a low dose of aspirin after childbirth can lower the chance of developing breast cancer later. You may be asked to provide blood, urine, and breast tissue samples so researchers can look for changes that could explain why aspirin may help.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
This trial tests an experimental drug called HMI-115 to see if it reduces pain from endometriosis. If you have moderate to severe period pain and non-period pain, and you have a surgical diagnosis, you may be able to join.
This early-phase study tests whether adding aspirin to standard neoadjuvant chemotherapy can change immune (anti-tumor) features inside ovarian, fallopian tube, or peritoneal tumors. It may help doctors better understand which patients respond and how aspirin could make treatment work better.
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
Hear when a new Endometrial Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.